#lipoatrophy

A side effect of some HIV meds, lipodystrophy results in a redistribution of fat.

Lipodystrophy, or abnormal changes in fat distribution, is a common problem among people living with HIV.

What is lipodystrophy and what causes it?

While newer antiretrovirals have reduced the prevalence of lipodystrophy, a significant proportion of the HIV population still suffers from th...

A prominent AIDS activist is asking people with HIV and the organizations that serve them to sign on to a letter asking the agency that sets r...

HIV-positive individuals experiencing a loss of muscle mass and an increase in abdominal fat may face an increased risk of death, according to...

HIV might damage cellular mitochondria, the suspected cause of face and body fat loss attributed to older antiretroviral (ARV) medications. Th...

Up to 19 percent of people who received Bio-Alcamid (polyalkylimide) for HIV-related facial wasting (lipoatrophy) at a Toronto clinic experien...

None of several factors sometimes associated with poorer cardiovascular health—trunk fat accumulation, limb fat loss, or modern protease...

In states where it is legal, medical marijuana helps some HIV-positive people cope with living their lives.

Healthcare Common Procedure Coding System (HCPCS) numbers have been assigned to two facial fillers for HIV-related lipoatrophy, which should m...

Avandia (rosiglitazone) significantly improved HIV treatmentÃ¢€“related limb fat loss (lipoatrophy) in people who stop taking Zer...

The Center for Medicare and Medicaid Services (CMS) announced March 23 that it will begin covering the cost of U.S. Food and Drug Administrati...

Truvada (tenofovir and emtricitabine) is more likely to lead to bone loss than Epzicom (abacavir and lamivudine); in addition, Norvir (ritonav...

Medicare administrators are offering a proposal to use approved injectable fillers to treat people with HIV who have facial wasting—but...